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its own is sufficient to stimulate pulsatile GnRH secretion. 
Moreover, our findings suggest that NKB action is proximal 
to kisspeptin in the reproductive neuroendocrine cascade 
regulating GnRH secretion, and may act as an autocrine 
modulator of kisspeptin secretion. The ability of continuous 
kisspeptin infusion to induce pulsatile gonadotropin secre-
tion further indicates that GnRH neurons are able to set up 
pulsatile secretion in the absence of pulsatile exogenous
kisspeptin.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 The seminal discovery of gonadotropin-releasing hor-
mone (GnRH)  [1] and subsequent studies have categori-
cally established its role as the final neuroendocrine con-
duit for control of the gonadotropins, luteinizing hor-
mone (LH) and follicle-stimulating hormone (FSH) by 
diverse central nervous system inputs  [2, 3] . LH and FSH 
act in concert to stimulate sex steroid secretion and ga-
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 Abstract 
 Pulsatile gonadotropin-releasing hormone (GnRH) is crucial 
to normal reproductive function and abnormalities in pulse 
frequency give rise to reproductive dysfunction. Kisspeptin 
and neurokinin B (NKB), neuropeptides secreted by the same 
neuronal population in the ventral hypothalamus, have 
emerged recently as critical central regulators of GnRH and 
thus gonadotropin secretion. Patients with mutations result-
ing in loss of signaling by either of these neuroendocrine 
peptides fail to advance through puberty but the mecha-
nisms mediating this remain unresolved. We report here that 
continuous kisspeptin infusion restores gonadotropin pulsa-
tility in patients with loss-of-function mutations in NKB 
( TAC3 ) or its receptor ( TAC3R ), indicating that kisspeptin on 
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metogenesis in the testes and ovaries. Appropriate gonad-
otropin pulse frequency and amplitude is crucial for nor-
mal reproduction  [2, 4] and disruption is associated with 
pathological conditions such as hypothalamic amenor-
rhea (low pulse frequency)  [5] and polycystic ovarian syn-
drome (high pulse frequency)  [6] . However, the precise 
mechanisms whereby inputs such as metabolic status and 
sex steroids regulate GnRH secretion remained cryptic as 
GnRH neurons lack requisite receptors, estrogen recep-
tor alpha  [7] and leptin  [8] .
 Recent discoveries of naturally occurring mutations 
have revolutionized our understanding of the neuroen-
docrine regulation of gonadotropins  [2, 9, 10] . The dis-
covery that mutations in the human and rodent G-pro-
tein-coupled receptor 54 (GPR54 also referred to as 
KISS1R) resulted in failure to progress through puberty 
and achieve adult reproductive function  [11, 12] led to the 
recognition that GPR54 and its cognate ligands, kiss-
peptins, are required for GnRH release and downstream 
gonadotropin secretion. The localization of kisspeptins 
to arcuate nucleus (ARC) neurons  [9, 10, 13, 14] , and its 
potential involvement as a component of the GnRH pulse 
generator  [9, 13, 14] , suggested a role for kisspeptin in the 
regulation of GnRH pulse frequency. This postulate is 
supported by a slowing of LH pulse frequency after kiss-
peptin antagonist injection into the ARC of rats  [15] and 
an increase in LH pulse frequency after kisspeptin ad-
ministration in men  [16] . Kisspeptin neurons express re-
ceptors for sex steroids which modulate kisspeptin gene 
expression, thereby providing a relay for steroid hormone 
feedback on GnRH neuron regulation  [9, 10, 13, 14] .
 Kisspeptin neurons in the ARC have been shown to 
also express neurokinin B (NKB) and dynorphin A (DYN) 
peptides  [13, 14, 17, 18] and are therefore called KNDY 
neurons  [13] . Inactivating mutations in the genes encod-
ing NKB ( TAC3 ) and its cognate receptor, NK3R ( TACR3 ), 
have also been recently shown, like GPR54 mutations, to 
result in hypogonadotropic hypogonadism; characterized 
by a failure to progress through puberty  [19, 20] . In con-
trast,  TACR3- inactivating mutation in mice does not re-
sult in a phenotype of reproductive deficiency  [21, 22] .
 In order to contribute to an understanding of the hi-
erarchy of roles of kisspeptin and NKB in the neuroen-
docrine control of GnRH pulsatility, we have admin-
istered kisspeptin to patients with hypogonadotropic
hypogonadism resulting from naturally occurring loss-
of-function mutations in the NKB ligand and its recep-
tor. These patients are characterized by very low LH but 
normal or near-normal FSH circulating concentrations 
 [19, 20] , consistent with low GnRH pulse frequency  [23] . 
In contrast, inactivating mutations in the kisspeptin re-
ceptor result in low circulating concentrations of both 
LH and FSH  [11, 12] . Since GnRH neurons express the 
GPR54 receptor but apparently not NK3R in sheep and 
mice  [18, 24, 25] and kisspeptin (KNDY) neurons ex-
press NK3R  [26–28] , we hypothesized that NKB secreted 
from KNDY neurons acts in an autocrine or paracrine 
manner to enhance kisspeptin secretion, and that kiss-
peptin alone is sufficient to elicit GnRH pulsatility. To 
test this postulate we infused kisspeptin at a GPR54-
saturating concentration in patients with  TAC3- and
 TACR3- inactivating mutations and demonstrated a res-
toration of LH pulsatility. This is the first indication of 
cooperative interactions of neuropeptides within a single 
neuronal population eliciting a pulsatile output essential 
for human health, and provides information on the hier-
archy of kisspeptin and NKB in regulating GnRH secre-
tion in humans.
 Methods 
 Participants 
 Patients 1 and 2 were 21- and 31-year-old men harboring the 
c.209-1G_C homozygous mutation in the NKB gene ( TAC3 )  [20] . 
This mutation is located in the IVS3 acceptor splice-site and un-
masks a cryptic splice-site in IVS3, leading to the insertion of 22 
nucleotides between exons 3 and 4 in the transcript. This inser-
tion results in a frame-shift downstream of codon 67 and the 
emergence of a premature stop codon at position 76, causing the 
termination of translation upstream of the NKB coding region. 
Patient 3 was a 26-year-old woman with a homozygous deletion 
(c.483_499del) in the gene encoding NK3R ( TACR3 ). This dele-
tion leads to a frame-shift downstream of codon 161 resulting in 
a premature stop codon at position 183 truncating  TACR3 after 
the third transmembrane domain.
 Patient 4 was a 28-year-old man harboring the homozygous 
c.738-1G_A mutation in the  TACR3 gene. This results in the loss 
of the natural splice acceptor site of intron 2 resulting in the trun-
cation of the receptor after the second extracellular loop, thus 
eliminating transmembrane domains 5–7 and the associated in-
tracellular and extracellular loops  [20] .
 Testosterone enanthate therapy in the 3 male patients and es-
trogen-progestin replacement therapy in the female patient were 
discontinued at least 3 months before evaluation.
 Protocol 
 Kisspeptin-10 was custom-synthesized under GMP standards 
(Bachem GmbH, Weil am Rhein, Germany) and reconstituted in 
5 ml sterile physiological saline as previously described  [16] . The 
Paris Sud University and Bicêtre Hospital Ethics Committees ap-
proved the study and all participants gave their informed consent. 
Subjects were admitted to the Bicêtre Hospital at 08: 00 h for 12 h 
of blood sampling every 10 min for 2 consecutive days as previ-
ously described  [20] . Vehicle (NaCl 0.9%) or kisspeptin-10 (1.5 
  g/kg/h was infused intravenously from 08: 30 to 20: 30 h on days 
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1 and 2, respectively). There were no adverse events related to
kisspeptin-10 or vehicle infusions.
 Hormone Assays 
 Serum LH, FSH, inhibin B, testosterone and estradiol levels 
were measured by immunoassays as previously described  [29–32] . 
The detection limits of the LH and FSH assays were 0.12 and 0.2 
IU/l, respectively. The intra- and interassay coefficients of variation 
were 1.6 and 4.2% for LH and 2.7 and 5.5% for FSH, respectively.
 Statistical Evaluation of Gonadotropin Secretion 
 LH and FSH pulses were detected by the Thomas’ algorithm, 
by analysis of LH and FSH concentrations in samples collected at 
10-min intervals, as reported elsewhere  [20, 29, 30] . Mean serum 
LH and FSH levels during saline (n = 72 measurements of each 
gonadotropin) or kisspeptin (n = 72 measurements of each go-
nadotropin) infusions were compared in each of the 4 patients by 
the paired parametric t test.
 In the 3 male patients (subjects 1, 2 and 4;  table 1 ) mean serum 
testosterone levels (n = 12 measurements during each treatment), 
mean serum inhibin B levels (n = 12 measurements during each 
treatment) and mean serum estradiol levels (n = 12) were com-
pared by the paired parametric t test.
 Statistical differences in mean pulse frequencies, hormone 
concentrations and area under the curve (AUC) were analyzed 
using GraphPad Prism 5 using a paired t test, where one-tailed p 
values  ! 0.05 were considered statistically significant.
 Results 
 The 2 patients with  TAC3- inactivating mutations and 
the 2 patients with  TACR3- inactivating mutations were 
of reproductive age between 21 and 31 years and have 
been previously described in detail  [20] . In this study we 
confirmed that they all had low circulating LH concen-
trations but normal or near-normal FSH, low inhibin B, 
low testosterone in the 3 males and low estradiol in the 
female patient ( table 1 ). Circulating LH and FSH concen-
trations and pulsatility during 12 h vehicle (saline) or
kisspeptin-10 (1.5   g/kg/h) infusions are shown in  fig-
ures 1 and  2 and in  table 1 . During the 12 h of vehicle in-
fusion (10-min sampling frequency) LH concentrations 
were lower than normal in all 4 patients with either ligand 
or receptor-inactivating mutations ( fig. 1 , 2 ;  table 1 ). Pa-
tient 2, who had the identical inactivating mutation to 
patient 1, had residual LH activity as there were two dis-
tinct LH pulses and a higher mean LH, albeit well below 
normal ( fig. 1 , 2 ;  table 1 ).
 Intravenous infusion of kisspeptin-10 elicited a slow 
initial LH response followed by a sustained reinstatement 
of LH pulses in all 4 patients and a concomitant increase 
in gonadal steroids and inhibin B ( fig. 1 ,  2 ;  table 1 ). There 
was also a significant increase in the mean LH concentra-
tion and LH AUC ( fig. 2 ). Although FSH concentrations 
were normal on vehicle fusion, there was a significant 
stimulation in mean concentrations and pulse frequency 
( fig.  1 ,  2 ;  table  1 ). Interestingly, quite a few of the FSH 
pulses were coincident with LH pulses, which is not read-
ily discernible in normal subjects.
 Discussion 
 Effects of Deficient NKB Signaling on Gonadotropins 
 The scenario of normal or near-normal FSH (2.1–5.4 
IU/ml) but low LH (0.2–0.62 IU/ml) and gonadal steroid 
levels in the patients with NKB signaling mutations is 
Table 1.  Mean (8SD) serum LH, FSH, inhibin B, testosterone and estradiol concentrations in patients with congenital hypogonado-
tropic hypogonadism caused by NKB (patients 1 and 2) or NK3R (patients 2 and 3) biallelic mutations receiving vehicle (saline) and 
then kisspeptin-10 (Kp10) infusion
Patient 1 (male) Patient 2 (male) Patient 3 (female) Patient 4 (male) Normal range1
saline Kp10 saline Kp10 saline Kp10 saline Kp10
LH, IU/l 0.2080.1 0.4080.2*** 0.6280.41 1.2180.60*** 0.2280.06 1.2580.56*** 0.4280.10 1.1280.43*** M: 2.6–6.5; F: 4–7.0
FSH, IU/l 2.980.2 3.480.5*** 4.480.6 7.181.1*** 2.180.1 4.280.9*** 3.080.2 5.480.7*** M: 2.7–7.4; F: 4–7.4
Inhibin B
pg/ml 15.983.2 27.484.6* 10.481.6 19.183.1* 8.1582.9 26.284.7** 6687.4 112813.7** M: 80–330; F: 60–125
Testosterone
ng/ml 0.1380.1 0.480.2* 0.1280.08 0.680.14* ND ND 0.4280.10 1.1280.43* M: 3.5–8.5
Estradiol
pg/ml ND ND ND ND 6.481.9 18.283.1** ND ND F: 25–90
D uring each treatment, 12 random measurements of inhibin B, testosterone and estradiol were performed. ND = Not determined. 
* p < 0.05; ** p < 0.01; *** p < 0.0001 (paired t test). 1 Normal hormonal range in postpubertal males (M) and females (F).
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 Fig. 1. Secretory pattern of LH and FSH in 2 patients with NKB  (TAC3) biallelic mutations (1 and 2) and 2 pa-
tients with NK3R  (TACR3) biallelic mutations (3 and 4) during infusion of saline ( j ) or kisspeptin-10 ( + ). As-
terisks denote LH pulses as identified with the Thomas’ algorithm. 
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 Fig. 2. Effects of continuous kisspeptin-10 on LH pulse frequency, mean LH levels and AUC: ( a ) mean ( 8 SEM) 
frequency of gonadotropin pulses, ( b ) mean ( 8 SEM) LH levels, and ( c ) mean ( 8 SEM) LH AUC in 4 patients 
with hypogonadotropic hypogonadism caused by NKB  (TAC3) or NK3R  (TACR3) mutations receiving vehicle 
(white column) and kisspeptin (black column).  *  p  ! 0.05 paired t test. 
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 Fig. 3. Schematic of proposed actions of a KNDY neuron on 
GnRH secretion summarizing findings from human and animal 
studies. Impacts of NKB and kisspeptin release on GnRH neuron 
secretion and LH and FSH responses in normal subjects (left) and 
patients with NKB- and NK3R-inactivating mutations (right). In 
normal subjects NKB acts in an autocrine (shown) or possibly 
paracrine (not shown) modality to reinforce kisspeptin secretion, 
which stimulates the GnRH neuron to secrete GnRH in pulses 
with a frequency interval of about 90 min. This results in corre-
sponding LH pulses and normal FSH levels. In patients with 
NKB-inactivating  (TAC3) and NK3R-inactivating  (TACR3) mu-
tations the absence of NKB stimulation of the KNDY neuron re-
sults in low kisspeptin secretion and resulting low GnRH pulse 
frequency with correspondingly low LH pulse frequency and am-
plitude, and lower end of normal FSH secretion. Continuous infu-
sion of kisspeptin overrides this deficiency to restore the normal 
pattern of LH pulses and a small increase in FSH. Note that the 
most parsimonious scheme involving kisspeptin and NKB is pre-
sented. In reality a greater complexity of regulation of the KNDY 
neuron including DYN and other regulators, as well as additional 
inputs into the GnRH neuron will be operative. 
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compatible with deficient (low) GnRH pulse frequency, 
which favors FSH gene transcription  [23] and secretion 
 [33] over that of LH. This contrasts with inactivating mu-
tations of kisspeptin signaling, which results in low cir-
culating concentrations of both gonadotropins  [2, 11, 12] . 
This also indicates that inactivating mutations of NKB 
signaling give rise to a less severe hypogonadotropic phe-
notype and suggests that NKB signaling is upstream of 
kisspeptin signaling in the neuroendocrine hierarchy of 
GnRH regulation.
 Both patients with inactivating mutations in  TACR3 
 and patient 1 with an inactivating mutation in  TAC3  had 
very low LH levels (0.2, 0.22 and 0.42 IU/ml) and no ev-
idence of pulses. Thus, inactivating mutations of either 
the ligand or receptor have a similar phenotype suggest-
ing that compensatory utilization of a ligand or receptor 
homolog does not occur. However, there have been re-
ports of spontaneous recovery of fertility in patients with 
mutations in NKB signaling  [34] but this did not take 
place in our patients. Interestingly, patient 2, who had 
the same mutations of  TAC3  as patient 1 and which result 
in a failure to produce active proteins, had higher LH 
(0.65 IU/ml) and two pulses during the control 12 h in-
fusion. This suggests that dependence of LH pulse gen-
eration on NKB input varies between individuals. Indi-
vidual variations in severity of phenotype have also been 
noted in kisspeptin and kisspeptin receptor knockout 
mice  [35] .
 Responses to Kisspeptin-10 Infusion 
 Continuous kisspeptin infusion stimulated LH re-
sponses but these were generally slower and at a lower 
concentration than that observed in our previous studies 
utilizing the same protocol in normal men  [16] and in 
other studies with acute administration of kisspeptin-10 
 [36] or kisspeptin-54 in man  [37] , or continuous infusion 
in sheep  [38] . However, the fold stimulation in the pa-
tients (mean 3.1-fold) was similar to that found in normal 
men (3.2-fold) receiving the identical continuous infu-
sion dose  [16] . The slower response and lower absolute 
level of response is possibly due to atrophy of GnRH neu-
rons and gonadotropes in the afflicted patients. In sup-
port of the latter, in previous studies on these patients, it 
was necessary to repeat GnRH stimulations (priming) to 
elicit a robust LH response  [20] . Recovery of the gonado-
trope with prolonged stimulation seems evident as the 
LH pulses increased in amplitude with increasing time of 
exposure to kisspeptin-10 ( fig. 1 ).
 The patients also exhibited an increase in FSH during 
kisspeptin infusion, indicating that, although FSH con-
centrations were normal, there is capacity for additional 
response with an increase in GnRH pulse frequency. The 
increase (mean 1.7-fold) was much lower than the LH in-
crease and similar to that seen for FSH in normal males 
(mean 1.8-fold)  [16] .
 There were also significant increases in inhibin B in 
all patients and in testosterone in the males and estradiol 
in the single female studied, reflecting the increases in 
LH and FSH.
 In addition to stimulating mean LH concentrations, 
continuous kisspeptin infusion clearly elicited pulsatile 
secretion of LH in all 3 of the patients who had an absence 
of LH pulses, and increased the pulse frequency from 2 
to 5 in patient 2 over the 12 h. While LH pulses were re-
stored to a frequency approaching normality (mean of
0.5 per hour compared with 0.7 per hour in our studies 
on untreated normal men) the amplitude and LH AUC 
was well below normal. This suggests that GnRH func-
tion is restored more readily than gonadotrope function 
after kisspeptin infusion. It may have been instructive to 
determine whether a continuation of kisspeptin infusion 
would have completely restored LH pulse amplitude and 
whether GnRH priming would have normalized the LH 
response to continuous kisspeptin infusion. Such studies 
will have to be the subject of future research as they were 
not feasible here for ethical and logistical reasons.
 We have previously reported that continuous infusion 
of kisspeptin-10 at the same dose (1.5   g/kg/h) increased 
the LH pulse frequency in normal men  [16] . Thus the cur-
rent findings support this observation but are even more 
persuasive as the baseline pulse frequency was nil or very 
low (mean 0.1 per hour) and was increased at least fivefold 
to 0.5 per hour. In contrast, the pulse frequency in
the normal men was increased from 0.7 to 1.0 per hour. 
Since LH pulses are well established to be coincident 
with, and dependent on, GnRH pulses  [39, 40 , also see 
reviews  2, 3, 41] , it is reasonable to interpret that continu-
ous kisspeptin-10 infusion in the current study increases 
GnRH pulse frequency.
 Kisspeptin-10 in GnRH Pulse Generation 
 A number of studies point to a role for kisspeptin in 
GnRH pulsatility in support of our findings. Kisspeptin 
is localized to KNDY neurons in the ARC  [13, 14, 17, 28] 
which is associated with GnRH pulse generation  [42, 43] , 
and kisspeptin stimulates GnRH neuron firing  [44–46] . 
Kisspeptin has also been shown to stimulate GnRH se-
cretion from hypothalamic explants  [47] , and in vivo in 
monkeys  [48] . Perhaps the most convincing evidence for 
a direct role of ARC kisspeptin in pulse generation was 
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the demonstration that administration of kisspeptin an-
tagonist in the ARC of ovariectomized rats decreased LH 
pulse frequency  [15] . Microdialysis studies in pubertal 
monkeys also demonstrated that intracerebroventricular 
kisspeptin antagonist inhibited GnRH pulses  [46] . Since 
the multi-unit electrical activity recorded in the ARC is 
coincident with LH pulses  [42, 43] it is tempting to pro-
pose that multi-unit electrical activity in the ARC will be 
correlated with pulsatile kisspeptin secretion which in 
turn generates GnRH pulsatility  [13, 14, 49] . However, 
our demonstration that continuous kisspeptin infusion 
increases LH pulse frequency in normal men and in our 
patients with NKB signaling deficiencies appears to run 
counter to this, and suggests that the delivery of kiss-
peptin to the GnRH neuron in a continuous modality is 
sufficient to entrain GnRH pulsatility, either indepen-
dently or in concert with other neural inputs. The sus-
tained stimulation of GnRH neuron firing on exposure 
to kisspeptin might be interpreted as supporting this sug-
gestion as the stimulation of firing lasts about 20 min 
 [44–46] which is much more protracted than a GnRH 
pulse. The above interpretation does not intend to imply 
that kisspeptin is not delivered to the GnRH neuron in a 
pulsatile modality  [48] but simply that, while kisspeptin 
is a prerequisite for GnRH pulsatile secretion, pulsatile 
delivery is not, and GnRH pulsatility is apparently inde-
pendent of kisspeptin pulsatility. There is evidence that 
GnRH neurons have the ability to independently gener-
ate pulsatile GnRH release  [50, 51] and kisspeptin input 
may reinforce this endogenous rhythm.
 It can be argued that the restoration of LH pulsatility 
in our patients might arise through a low level of endog-
enous kisspeptin pulsatility superimposed on the con-
stant circulating kisspeptin provided by continuous infu-
sion. However, this is an unlikely explanation as the infu-
sion dose we employed gives rise to near-maximum LH 
stimulation  [16] , thus negating any major contribution 
from endogenous kisspeptin. Moreover, constant infu-
sion of kisspeptin in normal men with normal LH pulsa-
tility was shown to increase LH pulse frequency  [16] .
 Hierarchy of NKB and Kisspeptin in GnRH 
Stimulation 
 The failure of humans with inactivating mutations in 
the kisspeptin/GPR54 or NKB/NK3R signaling systems 
to progress through puberty  [11, 12, 19, 20] , and the res-
toration of gonadotropin secretion by exogenous pulsa-
tile GnRH administration  [2, 20] indicates that these sys-
tems are proximal (upstream) to GnRH neurons. The 
ability to inhibit kisspeptin-stimulated gonadotropin re-
lease with GnRH antagonists and the localization of 
GPR54 to GnRH neurons further supports this conclu-
sion  [2, 9, 10, 13, 52] .
 While this proximal position of kisspeptin and NKB 
to GnRH in the neuroendocrine hierarchy is indisput-
able, the precise mechanism by which they interactively 
regulate GnRH pulsatility has not been established. An 
important outcome of our study is that kisspeptin alone 
in the absence of NKB signaling is sufficient to generate 
LH (and by inference GnRH) pulsatility, suggesting NKB 
actions are upstream of kisspeptin. Since NKB and kiss-
peptin are co-localized in the KNDY neurons in the ARC 
 [13, 14, 17, 18] (which plays a role in GnRH pulse genera-
tion)  [42, 43, 49] , the observation that continuous infu-
sion of kisspeptin can restore LH pulsatility in our pa-
tients suggests that NKB has an autocrine/paracrine ac-
tion to induce kisspeptin and thus GnRH secretion as 
schematically represented in  figure 3 . This is similar to 
schemes proposed by others  [13, 14, 26–28, 53] .
 Our deduction from the current findings that NKB 
operates upstream of GnRH neurons by stimulating kis-
speptin secretion from KNDY neurons, and not by direct 
activation of GnRH neurons, is supported by some data 
from animal studies. Firstly,  TAC3R is expressed in ARC 
KNDY neurons in mice  [27] , rat  [54] and sheep  [25] while 
 TAC3R expression was reported to be absent, or was not 
observed, in GnRH neurons of mice and sheep  [13, 25] . 
Secondly, studies on the effects of NKB and analogs in 
mice, monkeys, sheep and goats on LH secretion have 
suggested a modulatory role for NKB in the release of
kisspeptin by KNDY neurons in the ARC  [13, 14, 24, 27, 
28, 49, 55] . Thirdly administration of a NKB agonist to 
rats induced c-fos expression in KNDY neurons but was 
not observed in GnRH neurons in this study  [28] . Fourth-
ly, we have shown that kisspeptin antagonist alone slowed 
LH pulse frequency when administered into the ARC in 
ovariectomized adult rats  [15] and apparently slowed LH 
pulses in ovariectomized sheep  [46] . We have further 
supported the concept that NKB acts upstream of kiss-
peptin by demonstrating that the increase in LH pulse 
frequency resulting from treatment with the NKB ago-
nist, senktide, in intact juvenile female rats is prevented 
by kisspeptin antagonist [P. Grachev et al., unpubl. data]. 
Although these findings present a persuasive argument, 
there have been reports of TAC3R expression in rat GnRH 
neurons  [26, 54] which apparently runs counter to our 
interpretation. These contradictory reports on expres-
sion of the NKB receptor on GnRH neurons require reso-
lution through the demonstration of functional receptor 
protein or not in GnRH neurons. Interpretation of NKB’s 
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role in gonadotropin regulation is further complicated in 
rodents as it appears to have both inhibitory and stimula-
tory effects depending on physiological status  [27, 28, 56] 
and NKB knockout mice do not apparently have im-
paired reproduction in contrast to our patients  [21, 22] . 
The findings in rodent models therefore appear to differ 
from sheep  [24] , monkeys  [55] and now humans, which 
consistently demonstrate a stimulatory role for NKB up-
stream of kisspeptin.
 Therapeutic Implications 
 Our findings have implications for therapeutic inter-
ventions in various dysfunctions of the reproductive sys-
tem. In conditions of decreased LH production and near-
normal FSH secretion (i.e. due to low GnRH pulse fre-
quency) such as hypothalamic amenorrhea or delayed 
puberty  [5] , restoration of LH and normal reproductive 
function may potentially be achieved by treatment with 
NKB or kisspeptin agonists. Unlike GnRH that needs to 
be administered in a pulsatile manner to elicit augmenta-
tion of LH pulse frequency, it appears that kisspeptin can 
be administered continuously for at least 3 days [George 
et al., unpubl. data] to stimulate LH and gonadal steroid 
hormone secretion. Conversely, conditions characterized 
by high LH pulse amplitude and frequency such as poly-
cystic ovarian syndrome  [6] may be treatable by NKB an-
tagonists or kisspeptin antagonists. We have previously 
reported that kisspeptin antagonists reduce LH pulse fre-
quency and amplitude but do not lower basal LH levels 
 [15, 46, 57] in contrast to GnRH antagonist administra-
tion, suggesting that kisspeptin or NKB antagonists may 
be suitable for partial suppression of gonadotropins and 
gonadal steroids in hormone-dependent diseases, such as 
endometriosis and benign prostatic hyperplasia, without 
inducing bone loss or hot flushes that occur with GnRH 
analog therapy  [57] . A potential limitation in the thera-
peutic use of kisspeptin agonists is tachyphylaxis, which 
has been reported with long-term (2 weeks) administra-
tion of kisspeptin-54 to women with hypothalamic amen-
orrhea  [58] and rapidly in juvenile  [59] and adult  [53] 
monkeys. However, we have observed no evidence of 
tachyphylaxis in the current study and in men receiving 
continuous infusion of kisspeptin-10 at near-maximal 
LH-stimulating levels over 22 h  [16] .
 In summary, our findings that kisspeptin administra-
tion restores LH pulsatility in infertile patients with 
NKB- or NK3R-inactivating mutations have provided in-
sight into the hierarchy and interplay of kisspeptin and 
NKB in GnRH pulse generation in humans. The findings 
suggest a number of novel approaches to treating dys-
functions of the reproductive system and hormone-de-
pendent diseases.
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Errata
In the article ‘Effect of Ovarian Hormones on the Hypothalamic Excitatory Amino 
Acids System during Sexual Maturation in Female Rats’ by Carbone et al. [Neuroendo-
crinology 1995;61:235–242], the name of an author was published incompletely. The cor-
rect full name is Matilde E. Otero-Losada (i.e. Otero-Losada, M.E.).
In the article ‘Gonadotropin-Inhibitory Hormone Is a Hypothalamic Peptide That 
Provides a Molecular Switch between Reproduction and Feeding’ by Clarke et al. [Neu-
roendocrinology 2012;95:305–316], the second affiliation of Robert P. Millar was miss-
ing. It is ‘Mammal Research Institute, Department of Zoology, University of Pretoria, 
Pretoria, South Africa’.
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